Intellectual Property Cases
Cases 31 - 40 of 51
Ferring Pharmaceuticals Inc. et al v. Hetero USA Inc. et al
as 1:2019cv00634
Plaintiff: Ferring Pharmaceuticals Inc. and Ferring International Center S.A.
Defendant: Hetero USA Inc., Hetero Labs Limited and Hetero Labs Limited Unit-V
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. HETERO LABS LIMITED et al
as 2:2019cv05797
Plaintiff: CELGENE CORPORATION
Defendant: HETERO USA, INC., HETERO LABS LIMITED, HETERO DRUGS LIMITED and others
Cause Of Action: 15 U.S.C. § 1126
Genentech, Inc. et al v. Hetero Labs Limited et al
as 1:2019cv00178
Defendant: Hetero Labs Limited Unit V, Hetero Labs Limited and Hetero USA Inc.
Plaintiff: Genentech, Inc. and InterMune, Inc.
Cause Of Action: 35 U.S.C. § 271
Pharmacyclics LLC et al v. Hetero USA Inc. et al
as 1:2019cv00014
Defendant: Hetero USA Inc., Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Plaintiff: Pharmacyclics LLC and Janssen Biotech, Inc.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. HETERO LABS LIMITED et al
as 2:2018cv17463
Plaintiff: CELGENE CORPORATION
Defendant: HETERO USA, INC., HETERO LABS LIMITED, HETERO DRUGS LIMITED and others
Undetermined: HON. GARRETT E. BROWN, JR.
Cause Of Action: 15 U.S.C. § 1126
Pharmacyclics LLC et al v. Hetero USA Inc. et al
as 1:2018cv01778
Defendant: Hetero USA Inc., Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Plaintiff: Pharmacyclics LLC and Janssen Biotech, Inc.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. HETERO LABS LIMITED et al
as 2:2018cv14111
Plaintiff: CELGENE CORPORATION
Defendant: HETERO USA, INC., HETERO LABS LIMITED, HETERO DRUGS LIMITED and others
Cause Of Action: 15 U.S.C. § 1126
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al We have downloadable decisions or orders for this case
as 1:2018cv01043
Defendant: Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant: Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant: Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BIAL - PORTELA & CA S.A. et al v. Hetero Labs Limited et al
as 1:2018cv00342
Plaintiff: BIAL - PORTELA & CA S.A. , Bial - Holding, S.A. and Sunovion Pharmaceuticals Inc.
Defendant: Hetero Labs Limited , Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271
H. Lundbeck A/S et al v. Hetero USA Inc. et al
as 1:2018cv00176
Plaintiff: H. Lundbeck A/S , Takeda Pharmaceutical Company Ltd. , Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant: Hetero USA Inc. , Hetero Labs Limited and Hetero Labs Limited Unit-V
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?